| Literature DB >> 30949285 |
Olukemi Titilope Olugbade1, Adeniran Sunday Adeyemi2, Adedotun Hadizah Adeoti3, Olayinka Stephen Ilesanmi1, Saheed Oluwatoyin Gidado4, Ndadilnasiya Endie Waziri4, Mabel Kamweli Aworh1,5.
Abstract
INTRODUCTION: In November 2015 a measles outbreak was detected in several clustered settlements during the Northern Measles Supplementary Immunization Activities (SIAs) campaign in Gwagwalada, Nigeria, a measles outbreak was detected. Six weeks later another outbreak with 17 cases was reported in a different settlement in the same area council in December 2015 and January 2016. An outbreak investigation was initiated to characterize the outbreak in terms of time and person and implement prevention and control measures.Entities:
Keywords: Immunization; Nigeria; hard to reach; measles; outbreaks; surveillance; vaccination
Mesh:
Substances:
Year: 2019 PMID: 30949285 PMCID: PMC6441473 DOI: 10.11604/pamj.supp.2019.32.1.13368
Source DB: PubMed Journal: Pan Afr Med J
Figure 1Measles cases and deaths by date of onset of outbreak, Gwagwalada, Abuja-Nigeria, November 2015-January 2016 (n = 83)
Figure 2Distribution of measles cases and fatality by vaccination status in wards in Gwagwalada, Abuja-Nigeria, January 2015-January 2016 Nigeria (N = 119)
Figure 3Trend and distribution of suspected and confirmed measles cases in Gwagwalada, Abuja-Nigeria, January 2015- January 2016 (N =119)
Demographic and clinical characteristics of measles cases, Gwagwalada, Abuja, Nigeria November 2015-January 2016 (n = 83)
| Characteristics | Frequency (n) | Percentage (%) |
|---|---|---|
| < 9months | 2 | 2.4 |
| 9-60months | 54 | 65.1 |
| >60 months | 27 | 32.5 |
| Male | 44 | 53.0 |
| Female | 39 | 47.0 |
| Measles vaccine at 9 months | 5 | 6.0 |
| None | 12 | 14.5 |
| Unknown | 66 | 79.5 |
| Fever | 83 | 100.0 |
| Rash | 83 | 100.0 |
| Cough | 83 | 100.0 |
| Coryza | 73 | 87.9 |
| Conjunctivitis | 64 | 77.1 |
| Diarrhoea | 14 | 33.3 |
| Alive | 79 | 95.2 |
| Not alive | 4 | 4.8 |
Majority of the cases met the case definition criteria for measles infection. Most of the cases were within the 9-60months age group, were male, and up to 94% had not previously received measles vaccine or had unknown vaccination status
Coverage for measles vaccination during northern SIAs, Gwagwalada, Abuja-Nigeria, November 2015 N = 492,800 (total population), n = 83,776 (target population)
| Zero dose 9-11 months | Zero dose 12-59 months | Other dose 9-11 months | Other dose 12-59 months | Vaccine Use | Children vaccinated | Cummulative coverage (%) | |
|---|---|---|---|---|---|---|---|
| Day 1 | 1,063 | 1,307 | 3,633 | 17,497 | 24,610 | 23,500 | 28 |
| Day2 | 1,025 | 1,442 | 3,027 | 15,581 | 22,630 | 21,075 | 54 |
| Day 3 | 527 | 1,003 | 2,290 | 13,759 | 19,340 | 17,579 | 75 |
| Day 4 | 1,050 | 1,196 | 3,239 | 14,852 | 21,490 | 20,337 | 95 |
Close to 5000 children in the 12-59 months age range (6%) of children vaccinated had zero dose of measles vaccine, prior to the SIAs. The SIAs was completed with 95% coverage achieved